Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes
Ganna A Liubchenko, Holly C Appleberry, Christopher C Striebich, Karen E Franklin, Lezlie A Derber, V Michael Holers, Taras Lyubchenko, Ganna A Liubchenko, Holly C Appleberry, Christopher C Striebich, Karen E Franklin, Lezlie A Derber, V Michael Holers, Taras Lyubchenko
Abstract
Immune tolerance established during the development of B lymphocytes can be subverted in mature cells and lead to autoimmunity. This study focuses on the recently discovered subset of CD19(+)CD27(-)IgD(+)IgM(low/-) B cells that recognize self-antigens and have the capacity to produce autoantibodies, but under normal conditions do not generate autoimmune response due to intrinsic signaling inhibition (a condition known as clonal anergy and characterized by impaired antigen receptor signaling). Phosphorylation of intracellular signaling proteins and Ca(2+) responses in anergic B cells were measured by multicolor flow cytometry. Our results demonstrate a distinct phosphorylation pattern for major signal transduction proteins, which distinguishes anergic B cells. Comparison of B cell signaling properties in Rheumatoid Arthritis patients and healthy controls revealed a reversal of pTyr and Ca(2+) anergic signaling features in patients, accompanied by phosphorylation decreases of Blnk, Syk, SHP2, CD19. We identified BCR signaling pathway alterations associated with the loss of anergic B cell tolerance in Rheumatoid Arthritis.
Conflict of interest statement
Authors have no conflict of interest to declare.
Published by Elsevier Ltd.
Figures
Source: PubMed